FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending January 2009

 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

Notification of Transactions of Directors, Persons Discharging Managerial 
Responsibility or Connected Persons

I give below details of an increase in interests in Ordinary shares purchased at a price of £12.53 per share on 15 January 2009, and Ordinary share ADRs purchased at a price of $39.43 per ADR on 12 January 2009 in GlaxoSmithKline plc, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 January 2009.



Ordinary shares
ADRs
Mr A P Witty
224.23

Mr J S Heslop
0.01

Dr M M Slaoui
65.45

Mrs C E Bruck Slaoui
20.43

Mr S M Bicknell
29.20

Mr J M Clarke
139.42

Mr M Dunoyer
84.45

Mr E
 
J Gray
84.75

Mr D Learmouth
0.01

Mr W C Louv

44.55
Mr D J Phelan

135.99
Dr D Pulman

78.67
Mr D S Redfern
0.38

Ms C Thomas
0.74

Mr J R Stéphenne 
236.31




The Company was
 advised of this information on 
19 January 2009
.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


V A Whyte
Deputy 
Company Secretary

19 January 2009

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: January 19, 2009

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc